Freeline Therapeutics Holdings Plc

NASDAQ FRLN

Download Data

Freeline Therapeutics Holdings Plc Price to Earnings Ratio (P/E) on February 29, 2024

Freeline Therapeutics Holdings Plc Price to Earnings Ratio (P/E) is NA on February 29, 2024, a NA change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.
  • Freeline Therapeutics Holdings Plc 52-week high Price to Earnings Ratio (P/E) is -0.16 on June 09, 2023, which is NA below the current Price to Earnings Ratio (P/E).
  • Freeline Therapeutics Holdings Plc 52-week low Price to Earnings Ratio (P/E) is -6,843.53 on April 03, 2023, which is NA below the current Price to Earnings Ratio (P/E).
  • Freeline Therapeutics Holdings Plc average Price to Earnings Ratio (P/E) for the last 52 weeks is -1,149.78.
NASDAQ: FRLN

Freeline Therapeutics Holdings Plc

CEO Mr. Michael J. Parini J.D.
IPO Date Aug. 7, 2020
Location United Kingdom
Headquarters Stevenage Bioscience Catalyst, Stevenage, United Kingdom, SG1 2FX
Employees 152
Sector Healthcare
Industry Biotechnology
Description

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.

Similar companies

AVRO

AVROBIO Inc

NA

NA

IMMX

Immix Biopharma Inc

NA

NA

HEPA

Hepion Pharmaceuticals Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email